Clinical Trial Update: Heterotopic Implantation Of the Edwards-Sapien Transcatheter Aortic Valve in the Inferior VEna Cava for the Treatment of Severe Tricuspid Regurgitation (HOVER) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating heterotopic implantation of the Edwards SAPIEN transcatheter aortic valve in the inferior vena cava for severe tricuspid regurgitation …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tricuspid Regurgitation

Drugs mentioned

• Edwards SAPIEN Transcatheter Heart Valve (SAPIEN transcatheter heart valve)

Snippet

Sponsor: Henry Ford Health System | Conditions: Tricuspid Regurgitation | Phase 3 | Status: COMPLETED | Results posted: 2025-06-10